Firstly vascular approach,44 in which thrombolysis with tissue plasminogen activator (tPA) is used as a first-line option.1,4 In spite of using this therapy, morbidity of stroke is still high,4 indicating the effectiveness of tPA therapy is doubtful. The gene discussed is PLAT; the disease is Stroke.